Research in Uruguay shows that alcohol and energy drinks are the most consumed drugs by teenagers, surpassing marijuana and highlighting the risks of legal products

On Deusa Cast, lawyer Larissa Meneghel details how the five-year deadline set forth in RDC-327 for clinical cannabis research works and comments on the renewal proposal under review by Anvisa

Entrepreneur and CEO of Simply Pure is running for the seat in Colorado's First District advocating for full cannabis legalization and greater regulatory fairness for the sector, as stated to the US portal MJBizDaily

While PubMed registers record publications, JAMA review questions the robustness of evidence; understand the current scenario of cannabis research

According to Filipe Campos, from Close-Up International, the market could expand even further with rule updates and greater medical adherence

Caco Ciocler reinforces the importance of discussing cannabis openly and maturely, understanding its impacts without prejudice, when commenting on his son's experience as a cannabis farmer in Canada

Anvisa points out the USA as the main supplier, followed by Canada, Colombia, and Uruguay

In Deusa Cast, a lawyer explains how Customs and Criminal Law act in preventing risks in the importation of cannabis-based products, ensuring safety and agility for companies in the sector

In Deusa Cast, Larissa Meneghel explains how sanitary law is essential for cannabis-based products to reach pharmacies safely and with quality

New FDA study shows that CBD can cause liver damage in some people. Understand the risks, symptoms, and what to do to use it safely

Moving from Schedule I to Schedule III could unlock research, ease tax hurdles, and impact state markets

Proposal redefining limits and banning derivatives with total THC advances in the Senate with White House support